Clinical trials - Press Releases

Date	Title	Company
21-Oct-2025	selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease	selectION, Inc.
20-Oct-2025	ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors	ImmunOs Therapeutics
17-Oct-2025	STEMart Launches Advanced Bacterial Reverse Mutation Test (Ames) Service to Accelerate Medical Device Safety Assessment	STEMart
17-Oct-2025	CD Bioparticles Launches Advanced Tumor Organoid & CAF Co-culture Service to Accelerate Cancer Research	CD Bioparticles
17-Oct-2025	Creative Diagnostics Introduces OGN™ Tumor-derived Organoid Culture Kits to Advance Cancer Research	Creative Diagnostics
16-Oct-2025	LLRI – Learning Labb Research Institute: Your Path to Healthcare & Life-Sciences Careers	Learning Labb Research Institute
15-Oct-2025	Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14	Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14
14-Oct-2025	Almac Trial Coordinator Launched in $48 Million Investment to Advance Integrated eClinical Technologies	Almac
13-Oct-2025	New medical writing service provider QInscribe reduces the time to generate a draft clinical study report (CSR) by 90% with generative AI solution	QInscribe
09-Oct-2025	New GCP Training Aligned with ICH E6(R3) from Pharma Lessons	Pharma Lessons
09-Oct-2025	FDA Approves Libtayo as First Immunotherapy for Adjuvant Treatment of CSCC	Regeneron Pharmaceuticals, Inc.
09-Oct-2025	Orexa Announces Positive Interim Data for its Phase 2 Trial in the Prevention of Post-Operative Ileus	Orexa
08-Oct-2025	Citeline Launches AI Importer to Optimize Global Clinical Trial Disclosure Workflows	Citeline
07-Oct-2025	CluePoints Proven AI Innovation Earns Dual Recognition at SCDM and SCRIP Awards	CluePoints
07-Oct-2025	TrialAssure Introduces Enhanced Architectural Techniques to Improve Accuracy, Visibility, Traceability, and Control Across its AI Platform for Pharma and Biotech	TrialAssure
01-Oct-2025	Phastar Scoops Multiple Finalist Positions in 2025 SCRIP Awards	Phastar
01-Oct-2025	Leqembi®▼(lecanemab) long-term 36-month open-label extension data from post-hoc sub-group analysis of ApoE ε4 non-carriers and heterozygotes presented at Alzheimer’s disease congress in Switzerland	Eisai Europe Ltd.
30-Sep-2025	NEW RELEASE: OptymEdge hires Senior Director to Drive Global Roll-Out of ACUVERA Platform	Defacto
29-Sep-2025	Pooled data presented at ERS: nerandomilast monotherapy linked to nominally significant reduction in risk of death in IPF and PPF	Boehringer Ingelheim
29-Sep-2025	Icotrokinra shows superiority to deucravacitinib in first reported head-to-head trials reinforcing promise of investigational targeted oral peptide for treatment of plaque psoriasis	Johnson & Johnson Innovative Medicine